Vuchkova J, Koltun M, Greive K, Comper WD. Do large pores in the glomerular capillary wall account for albuminuria in nephrotic states? Am J Physiol Renal Physiol 307: F525-F532, 2014. First published July 2, 2014; doi:10.1152/ajprenal.00228.2014.-Albuminuria in nephrotic states is thought to arise from the formation of large pores in the glomerular capillary wall as large hydrodynamic probes, like Ficoll, have increased fractional clearance. In the present study, we tested for large pore formation in a novel manner. We accounted for the rates of plasma elimination as determined for tritium-labeled tracers of uncharged polydisperse Ficoll (radii range: 35-85 Å) and two globular 14 C-labeled proteins, albumin (radius: 36 Å) and IgG (radius: 55 Å), in control and puromycin aminonucleoside nephrotic (PAN) Sprague-Dawley rats. The plasma elimination rates were then matched to the urinary excretion of these labeled materials (n ϭ 7). Albumin and IgG plasma retention rates were identical and far enhanced compared with the retention rates of inert transport markers of equivalent hydrodynamic radius; their elimination rate corresponded to the elimination of a 75-Å radius Ficoll (n ϭ 5) and Ͼ105-Å radius dextran (n ϭ 5). In PAN, they were eliminated as ϳ36-and ϳ55-Å radii Ficoll, respectively, equivalent to their hydrodynamic radii. In contrast, there was no comparable increase in the elimination rate of Ficoll in PAN. The total plasma clearance of Ficoll in control and PAN rats and the urinary clearance in PAN rats were essentially the same for all radii. On the other hand, the urinary clearance of Ͼ45-Å radii Ficoll in controls was considerably lower with increasing radii, demonstrating a postfiltration cellular uptake in controls, which, when inhibited in nephrotic states, would account for apparent large pore formation.
THE MECHANISM OF ALBUMINURIA in nephrotic states has generally been discussed in terms of a loss of glomerular permselectivity (17) . The concept of "large pores" developing in the glomerular capillary wall as an underlying mechanism of albuminuria has been primarily derived from the observation that the fractional clearance of tritium-labeled Ficolls or dextrans of large radii (Ͼ50 Å) increases in nephrotic states (2) . Previous studies by Bohrer et al. (3) compared the fractional clearance to that of the ratio of material in Bowman's space (determined by micropuncture) to plasma material for Ficolls with a radius range of 22-40 Å. They demonstrated that they were essentially identical, indicating no significant cellular reabsorption postfiltration. Cellular uptake of Ficolls with higher radii has not been studied, but it has been assumed not to occur. The large pore concept, as a primary mechanism of albuminuria, takes on even greater importance as the original concept of charge selectivity or charge-related effects, thought to restrict transglomerular transport of albumin, has been shown to be of minor influence (1, 6 -8) .
A major assumption with the large pore concept is that large hydrodynamic probes do not undergo postfiltration cellular uptake, which would yield an apparent excessive restriction of the fractional urinary clearance in control animals. The lack of significant reabsorption of inert transport probes has only been established for dextran and Ficoll of relatively low radii (Ͻ45 Å) (3) (4) , but it is precisely above this radius that large pores are apparent. Measuring reabsorption of high-molecularweight dextran and Ficoll probes that have been filtered would be difficult as they would have very low glomerular sieving coefficients (GSCs), and therefore their concentration in the filtrate may be too low to accurately measure by micropuncture. However, there is important evidence showing that large radii probes are taken up by proximal tubular cells. Dunn et al. (11) demonstrated internaIization of 500,000 molecular weight fluorescein dextran into endosomes of proximal tubular cells after micropuncture injections of dextran into the lumen of the proximal tubule of rats. Large carbon nanotubes (length Ͼ 100 Å) have also been demonstrated to be filtered and taken up by proximal tubules (30) .
In this study, large-pore formation was generated in the glomerular capillary wall using an experimental nephrotic condition induced by puromycin aminonucleoside (PA). This agent generates oxygen radicals (25) known to cause loss of organization of the interdigitating foot processes of the podocyte and podocyte detachment from the glomerular basement membrane (22) . PA is known to have a specific effect on the kidney, as it does not affect extrarenal microvascular permeability to albumin (26) . To understand the role of large pores in this nephrotic condition, we examined and accounted for all aspects of the plasma elimination of both IgG and albumin and their appearance in urine. Their behavior was compared with the plasma elimination and urinary appearance of Ficolls (35-85 Å) and plasma elimination of dextrans (50-105-Å radii).
MATERIALS AND METHODS
Experimental animals. All animal experiments were approved by the Animal Ethics Committee of Monash University and conducted in accordance with its guidelines. Male Sprague-Dawley rats (weight: 350 -450 g, age: 10 -12 wk) were obtained from the Monash University Central Animal House (Melbourne, Victoria, Australia). Throughout the experimental period, rats were maintained under a 12:12-h day-night cycle with free access to standard rat food and water.
Radioisotopes. Induction of PA nephrosis. Induction of PA nephrosis (PAN) was performed as previously described (27) . Rats were injected intravenously, via the tail vein, with PA (Sigma, St. Louis, MO) as a 3.5% solution in PBS at a concentration of 10 mg/100 g body wt (27) . Urine was collected in metabolic cages over a 24-h period at baseline (day 0) and on days 5 and 8 after PA administration. Total urinary protein excretion was determined [Biuret assay (16) ] at each of these days to ensure the onset of proteinuria. Those rats that excreted Ͼ400 mg/24 h by day 8 were considered proteinuric and were included in the study. Peak proteinuria was generally achieved 9 days after PA administration. Experiments were therefore performed on day 9 after the injection of PA or PBS. The data shown in Tables 1 and 2 demonstrate that the effects of PA toxicity on the parameters measured were uniform, with P Ͻ 0.001 in general for total protein excretion, urine flow rate, plasma albumin concentration, albumin excretion rate, and plasma elimination rates, as expected.
Radiolabeling of tracer molecules. Rat serum albumin (RSA; fraction V, Sigma) and rat IgG (Sigma) were labeled with 14 C ([ 14 C]formaldehyde, NEN, DuPont) using a modified reductive methylation procedure as previously described by Eng (12) . Protein (25 mg) was dissolved in 2.5 ml buffer containing 100 mM HEPES (pH 7.5), 2 mM NiCl 2, and 20 mM NaCNBH3. To this mixture was added 125 Ci [ 14 C]formaldehyde, and the mixture was incubated at 37°C for 30 min. Cold formaldehyde (1 mol) was then added (freshly prepared by dissolving 3 mg paraformaldehyde in 1 ml distilled water). The mixture was incubated at 37°C for an additional 90 min and then dialysed against several changes of PBS at 4°C until no radioactivity was detected in the dialysate. To check for purity, each labeled protein sample was examined using a Sephadex G-100 column to confirm the absence of degraded material, free label, or aggregated material. Before use, the integrity of each labeled preparation was analyzed again using size-exclusion chromatography. The specific activity of each labeled preparation was determined by analysis of the radioactivity in the solution and analysis of the protein content, as determined by the Biuret assay. The specific activity of [ 14 Koltun et al. (23) . One hundred milligrams of each polysaccharide were dissolved in 1 ml of 0.1 M NaOH, and 10 mCi sodium boro-[ 3 H]hydride was added. The reaction was allowed to proceed overnight (ϳ18 h) at room temperature. Two drops of phenol red were added as a pH indicator (pH 6.8 -8.4). This was then acidified with 0.1 M acetic acid by a reaction with excess sodium boro-[
3 H]hydride. The solution was neutralized with 0.1 M NaOH, and the volume was adjusted to 2.5 ml with distilled water and then applied to a Sephadex G-25 PD-10 column preequilibrated with PBS. The polymer peak fraction was collected, placed in benzoylated dialysis tubing, and dialysed extensively against distilled water for 3 days and then against 0.15 M NaCl solution for 2 days at 4°C. The integrity of the labeled preparation was analyzed using a Sephacryl S-400 (for dextran) or Sephacryl S-300 (for Ficoll) column to confirm the absence of degraded material, free label, or aggregated material. All preparations were stored at 4°C. Before use, the integrity of the each labeled preparation was checked again using size-exclusion chromatography. The hexose content of each preparation was determined for the estimation of specific activity by the hexose assay. 7 dpm). Blood samples were taken from the tail vein at 3, 6, and 16 h postadministration of the radiolabeled tracers. At 24 h, rats were anesthetized and euthanized. Urine was collected over the 24-h period. Collected blood and urine samples were prepared for analysis.
Size-exclusion chromatography. Plasma samples containing radiolabeled dextran were analyzed using a Sephacryl S-400 (Pharmacia) column (2 ϫ 66 cm 2 ). Plasma and urine samples containing radiolabeled Ficoll were analyzed using a Sephacryl S-300 (Pharmacia) column (2 ϫ 66 cm 2 ). Both Sephacryl S-400 and S-300 columns were calibrated with standard molecules of known radii. Samples were eluted with PBS (pH 7.4 containing 0.2% BSA to minimize adsorp- Data are means Ϯ SD; n, number of determinations. The plasma concentration of albumin was measured by radioimmunoassay. The albumin excretion rate was measured by radioactivity (measures both intact plus peptides) in the control group and by radioimmunoassay (measures intact albumin) in the puromycin aminonucleoside nephrotic (PAN) group. *P Ͻ 0.001 vs. the control group. Table 2 . Pharmacokinetic parameters of albumin (23) Data are means Ϯ SD; n, number of determinations. *P Ͻ 0.05, †P Ͻ 0.001, and ‡P Ͻ 0.0001, PAN group vs. control group. tion and 0.02% azide to prevent bacterial contamination) at 4°C at a flow rate of 20 ml/h (Sephacryl S-300) or 30 ml/h (Sephacryl S-400), and fractions of ϳ1.7 ml were collected, with recoveries Ͼ90%. Each column was calibrated using blue dextran T2000 (M w ϭ ϳ2,000,000) at a concentration of 2 mg/ml and tritium-labeled water (NEN) at a concentration of 4 ϫ 10 4 dpm/ml to determine the void volume and total volume of the column, respectively. Samples for analysis were made up to 1 ml with elution buffer before being applied to the top of the column. The Sephacryl S-400 column was calibrated using FITC dextrans (M w ϭ 69.7, 134, 191, and 263 kDa; Mn ϭ 45.5, 106.7, 152, and 217 kDa, where M n is the number-averaged molecular weight) of different molecular sizes (molecular radius ϭ 60.4, 74.7, 82.4, and 89.4 Å). The molecular radius for each of the FITC dextrans was determined from the radius versus molecular weight relationship for dextrans as determined by Granath and Kvist (13) . The Sephacryl S-300 column was calibrated with radiolabeled proteins of known molecular size, namely, albumin (radius: 36 Å), transferrin (radius: 48 Å), IgG (radius: 55 Å), and glucose oxidase (radius: 70 Å). The available volume of material fractionated on the column (K av) was deterimed by the following formula:
where V e is elution volume of material, Vo is void volume, and Vt is total volume. For each column calibration, a linear relationship was obtained for the plot of radii versus K av (r ϭ 0.993 and 0.999 for Sephacryl S-300 and Sephacryl S-400 columns, respectively). Other radii estimates were obtained by both interpolation and extrapolation of this plot.
Albumin radioimmunoassay. The radioimmunoassay used 125 Ilabeled RSA ([ 125 I]RSA) prepared using the chloramine T method (14) . [
125 I]RSA was routinely purified by size exclusion using PD-10 columns with the peak fraction stored at Ϫ80°C. Other reagents for the radioimmunoassay included rabbit antiserum (polyclonal) to rat albumin and sheep anti-rabbit antibodies. The urinary albumin concentration measured by this double-antibody radioimmunoassay had an interassay coefficient of variation of 7% at a concentration of 180 ng/ml. The detection limit of the assay was 31.2 ng/ml. The standard curve was prepared using a RSA standard (1 mg/ml) that was diluted to give a range of 4,000 to 31.2 ng/ml.
Elimination rate of radiolabeled tracers. Radioactive material in the blood (sampled at 3, 6, 16, and 24 h postadministration of the tracer) was quantified at each time point and presented on a semilogarithmic plot of plasma radioactivity versus time. The plasma elimination rate constant of each tracer was determined from the decrease in log plasma radioactivity over the 3-to 24-h period (linear regression coefficient Ͼ 0.98). The plasma elimination rate constant was the gradient of this plot (29) . Volume of distribution (the extent of material distribution in the body after intravenous administration) was determined for each tracer as the dose administered (in dpm) Ϭ plasma concentration of the tracer (in dpm/ml) as a function of time (29) . Plasma clearance from the circulation was calculated as the plasma elimination rate constant (in h Ϫ1 ) ϫ volume of distribution of each tracer (in ml). Multiplication of the plasma clearance of albumin by the plasma albumin concentration (in mg/ml) gives total albumin loss (in mg/h).
Urinary clearance of Ficolls. The steady-state clearance of Ficolls (radii range: 34 -74 Å) using osmotic pumps over 7 days has been previously described by Greive et al. (15) . Alzet osmotic pumps were filled with polydisperse [
3 H]Ficoll 70 along with 0.002% (wt/vol) thimerosal to inhibit bacterial growth. Alzet osmotic pumps (model 2001) have a mean filling volume of 227 Ϯ 6 l, pumping rate of 0.96 Ϯ 0.04 l/h, length of 3 cm, diameter of 0.7 cm, and unfilled weight of 1.1 g. Once filled, the pumps were then incubated in PBS for 4 h at 37°C. The concentration of radioactivity initially in the pump was 2.5 ϫ 10 8 dpm/ml for polydisperse [ 3 H]Ficoll. Rats were anesthetized with ether, and the osmotic pumps were implanted subcutaneously between the scapulae using sterile techniques. Rats were then maintained as pairs in rat boxes with free access to food and water at all times and were placed in metabolic cages on days 2, 5, and 7 for 24 h, where urine collections and the corresponding plasma samples were taken at the end of the urine collection period. Both blood and urine samples were centrifuged at 3,000 rpm in a KS-5200C Kubota bench top centrifuge (Kubota, Tokyo, Japan) for 10 min and then analyzed for radioactivity. Samples were taken on days 2, 5, and 7 to ensure that steady state was reached on day 7. The glomerular filtration rate was determined by the creatinine assay (10) . The urine flow rate was determined by measuring the volume of the 24-h urine collection (in ml).
Digestion of rat organs. At the end of the experimental period (after cardiac puncture), organ tissues such as the kidney, liver, spleen, and muscle were excised from the rats, washed externally with PBS, and weighed. Each tissue (whole kidney, whole spleen, 1-2 g of liver, and 1-2 g of muscle) was minced, and 1.4 M NaOH was added to make a final volume of 6 ml. Samples were covered loosely and immersed in boiling water for 15-30 min to allow complete digestion of the organ tissues. Three 100-l sample aliquots of each organ digest were taken, to which was added 50 l hydrogen peroxide [30% (wt/vol)] to decolorize the samples. The volume of each sample was made up to 1 ml with distilled water before being added scintillation fluid. Before radioactivity was counted, samples were stored in the dark overnight to minimize chemiluminescence interference with radioactive counting. The presence of the radiolabeled tracer in the organ tissues was determined and expressed as dpm per gram of tissue or as percentage of the injected dose. When values are expressed as percentages of the injected dose, it was assumed that total liver mass equals 2.5% of the body weight and that total muscle mass equals 25% of the body weight (18, 24) .
Counting of radioactivity. Radioactivity from 3 H-labeled or 14 Clabeled material was determined by ␤-scintillation counting in a Wallac 1409 liquid scintillation counter with internal standards using a 1:3 aqueous sample-to-Optiphase scintillant ratio. When samples contained both 3 H-and 14 C-labeled material, a dual-label protocol was used to determine the radioactivity from each isotope. Each sample was counted for 1 min. Radioactivity was expressed as dpm, where correction was made for quenching, chemiluminescence, and counterefficiency.
Statistical analysis. All quantitative data are expressed as means Ϯ SD unless stated otherwise, where n represents the number of determinations. Statistical differences were assessed using a two-tailed Student's t-test for unpaired data, with P values of Ͻ0.05 denoting statistical significance. Linear regression analysis was performed using SigmaPlot (version 4 for Windows 98, Jandel, San Rafael, CA) or Microsoft Excel.
RESULTS

[ 14 C]albumin and [
14 C]IgG as well as tritium-labeled Ficoll and dextran used in this study were not biochemically altered over the course of 24 h in the circulation, as determined by size-exclusion chromatography (not shown), which would otherwise affect their elimination rate from plasma. Similarly, [ 14 C]albumin in the circulation was not altered over the course of 7 days (not shown).
The intravenous administration of PA to rats resulted in a significant increase in proteinuria (Table 1 ) from 2.6 Ϯ 0.3 mg/h (n ϭ 12) in control rats to 21.8 Ϯ 4.7 mg/h (n ϭ 12) in PA-treated rats, as detected by the Biuret assay (16) . Proteinuria associated with PAN was to a large extent due to intact albuminuria from 0.025 Ϯ 0.012 mg/h (n ϭ 7) in control rats to 13.4 Ϯ 3.2 mg/h (n ϭ 7) in PA-treated rats as measured by the radioimmunoassay. A previous study (23) measured intact immunoglobulinuria from 0.96 Ϯ 0.36 g/h (n ϭ 7) in control rats to 206.4 Ϯ 56.4 g/h (n ϭ 7) in PA-treated rats. Table 2 shows the plasma elimination rate constant, the volume of distribution and clearance from the circulation of albumin and IgG respectively in control and PA-treated rats. The plasma elimination rate constant of albumin increased significantly (P Ͻ 0.0001) by 2.5-fold from 0.019 Ϯ 0.003 h Ϫ1 (n ϭ 18) in control rats to 0.050 Ϯ 0.011 h Ϫ1 (n ϭ 19) in PA-treated animals (from 15). The plasma elimination rate constant of IgG was similar to that of albumin in control rats, 0.019 Ϯ 0.003 h Ϫ1 (n ϭ 6), increasing significantly (P Ͻ 0.05) to 0.036 Ϯ 0.006 h Ϫ1 (n ϭ 6) in PA-treated rats. This was statistically different (P Ͻ 0.05) from the elimination rate of albumin in PA-treated rats (Fig. 1A) . There was a significant increase (P Ͻ 0.05) in the volume of distribution of albumin from 24.20 Ϯ 2.88 ml (n ϭ 18) in control rats to 32.72 Ϯ 9.90 ml (n ϭ 19) in PA-treated rats. The volume of distribution of IgG did not change significantly [17.64 Ϯ 5.05 ml (n ϭ 6) in control rats vs. 20.00 Ϯ 3.07 ml (n ϭ 6) in PA-treated rats]. The differential distribution (in the body) of albumin compared with IgG could be due to the difference in size between the two proteins, since capillary walls around the body exhibit greater size selective restriction to the elimination of larger molecules.
Albumin and IgG plasma retention rates were far enhanced compared with the retention rates of inert transport markers of equivalent hydrodynamic radius; their elimination rate corresponded to the elimination of a 75-Å radius Ficoll (n ϭ 5) and Ͼ105-Å radius dextran (n ϭ 5; Fig. 1 ).
The plasma elimination rate constant of Ficolls with a radii range of 36 -85 Å did not change significantly in PA-treated rats (15) (Fig. 1B) . It was the same for volume of distribution (Fig. 2 ) and total clearance (Fig. 3B) . On the other hand, for dextrans with a radii range of 50 -105 Å [note that a 53-Å radius dextran will have approximately the same GSC as albumin (32)], we did see significant increases in plasma elimination (65-90 Å; Fig. 1C) , volume of distribution (not shown), and total clearance (50 -95 Å; Fig. 3C ). It is most likely that dextran, as a random coil molecule, is not a suitable model for globular proteins in relation to plasma clearance studies. Its plasma elimination shows weak size dependence compared with urine size selectivity seen in both controls and nephrotic states (4) . Due to its linear random coil nature, its elimination is most probably governed by its access to nonrenal areas (volume of distribution) as distinct to globular spherical particles.
Further confirmation of the equivalence of globular proteins to Ficolls was demonstrated when the plasma elimination of albumin and IgG in PAN, where presumably cell uptake had been inhibited (31) , basically mirrored that obtained with equivalent radii Ficoll, i.e., they were eliminated as ϳ36-and ϳ55-Å Ficoll, respectively (Fig. 1) .
When accounting for the loss of albumin and IgG from the plasma in PAN compared with their increased urinary excretion, we found very good agreement (Table 3) given the Ͼ20% SD on measured excretion rates. We can account for Ͼ70% recovery in urine of material lost from the plasma in PAN. We also found similar results with Ficoll in that its elimination from the plasma in controls was the same as in PAN and was essentially equivalent to its appearance in urine in PAN (Fig. 4) . The massive divergence for the urinary clearance in PAN versus controls for Ficolls with radii Ͼ 55 Å in healthy controls would be typical of results interpreted as large pore formation in PAN. The elimination rate was calculated as the decline (gradient) in log plasma radioactivity over the 3-to 24-h period after intravenous administration of the labeled tracer. *P Ͻ 0.05 vs. control rats.
The tissue distribution of 14 C-labeled material, as a percentage of the injected dose of radioactivity, at 24 h after intravenous injection of [
14 C]RSA in control and PAN rats is shown in Table 4 . In both cases, we could account for ϳ45% of the injected dose, and this is in accord with previous studies (34, 35) that also identified major deposition of labeled albumin in skin, feces, and intestinal contents (not analyzed in this study). In control rats, most material was retained in the plasma, whereas in PAN rats, most of this had been excreted in urine. For controls or PAN, the extrapolation (to zero time) of the plasma value in the elimination phase (29) for both albumin and IgG is ϳ56% of the initial dose. Therefore, the amount being excreted in PAN represents ϳ65% of the initial elimination plasma value (36.52 ϫ 100/56%) or 100% of the material existing in control plasma (36.52 ϫ 100/28.81%).
DISCUSSION
Previous studies (2, 3) have suggested that Ficoll is the most suitable transport probe when modeling the transport of globular proteins because of its similarity in conformation to globular proteins like albumin. This was confirmed in this study when plasma elimination rates of albumin and IgG were examined. In PAN, both albumin and IgG were eliminated from the plasma at rates equivalent to Ficolls of the same hydrodynamic radius. This demonstrates that normal glomerular size selectivity was occurring in PAN. Contrary claims that Ficoll behaves very differently to albumin in terms of glomerular permeability (not charge related) have been made on the basis of the apparent ultralow GSC for albumin as measured by a glomerular uptake technique (28) . By this technique, after steady-state intravenous infusion of radiolabeled albumin is established, the vascular compartment of the kidney is then washed out for 8 min, and the amount of radioactivity remaining in the kidney is used to calculate the GSC for albumin. The potential error that has not been addressed in this system is that the relatively long washout time may remove rapidly retrieved albumin and therefore severely underestimate GSC. The influence of shorter washout times on this type of GSC measurement should be examined but has not been investigated. The first major piece of evidence demonstrating that large pores do not account for albuminuria in nephrotic states is the complete lack of change in the plasma elimination rate of Ficoll across all examined radii in PAN, particularly Ficolls with radii Ͼ 55 Å, which is in contrast to 1) the profound change in the urinary clearance of the corresponding Ficolls of increasing radii in control rats compared with PAN rats and 2) the major changes in the elimination rate of albumin and IgG in PAN. If large pore formation were responsible for the significant increase in albumin elimination rate, the elimination rate of Ficoll molecules with a radius Ͼ 55 Å or greater would be expected to increase accordingly, but this was not observed in this study.
In accounting for Ficoll material that leaves the plasma and the material that appears in the urine, it was apparent that the plasma elimination of Ficolls in the radii range of 36 -75 Å was similar in controls and PAN, and this eliminated material made up essentially what was cleared in PAN urine. The remarkable exception was that there was a divergence in the urinary clearance of Ficoll with radii Ͼ 50 Å in healthy controls (Fig.  4) compared with the plasma clearance in control and PAN and the urinary clearance in PAN. This is the classic profile that has been previously interpreted as being due to the formation of large pores in PAN. If there is no postfiltration cellular uptake, this would require that the tissue destinies of nonfiltered plasma-eliminated Ficolls be markedly different in controls (leading to less being filtered by the kidney) compared with PAN. The evidence clearly does not support this. For example, for a Ficoll radius of 74 Å, there is a two order of magnitude difference in its urinary clearance between control and PAN, yet there are no major differences in the volume of distribution (which accounts for the destinies of all plasma-eliminated Ficolls from the circulation) for controls in the radii range of 45-75 Å, in agreement with a previous study (26) , nor are there major differences in the volume of distribution for all radii between control and PAN rats (Fig. 2) . This would suggest that nonfiltered Ficolls (radii Ͼ 50 Å) in controls are not being redirected to other regions of the body (volume of distribution). Also, if there was an ϳ100-fold apparent increase in the glomerular permeability of 74-Å radius Ficoll in PAN (or any apparent increase in the clearance of Ficoll with radii Ͼ 50 Å), the expectation would be that there would be a significant increase in the clearance of 36-Å radius Ficoll; this was also not observed. The results shown in Fig. 4 point to the fact that the divergence is due to postfiltration cellular uptake of highradii Ficolls, which is inhibited in nephrotic states like PAN. The virtue of performing the mass balance, as done in this study, is that it provides the only method to understand the destiny of these high-radii Ficolls. There is no other technology available to quantitatively examine cell uptake of Ficoll when 1) Ficoll GSC Ͻ 0.001 and 2) it is difficult to ensure that uptake is irreversible as exocytosis of Ficolls back to the tubular lumen may not alter their fractional clearance. There does not seem to be any doubt, however, that proximal tubular cells are able to accommodate uptake of large molecules (11, 30) . We too have previously identified Ficoll uptake by the kidney (23) for similar preparations used in this study. If this was size independent, as expected through fluid-phase endo- cytosis, then the uptake would not be significant for Ficoll radii Ͻ 50 Å but would have increasing influence for increasing Ficoll radii Ͼ 50 Å. Overall, we cannot disprove the existence of large pores in nephrotic states, but the plasma elimination and urinary clearance data would suggest that their influence is far less than previously thought.
Rather than being able to account for albuminuria by changes in glomerular permselectivity, including the formation of large pores, in the nephrotic condition, we can do it by the disappearance of plasma protein and its equivalent appearance in urine. Specifically, we can account for the amount of either albumin or IgG excreted in the urine by their corresponding fall (ϳ70%) in plasma concentration in PAN (Table 3) , similar to that found previously (19 -21, 23, 26) , without any change in elimination in Ficolls of equivalent size. It is well established that inert transport probes with a hydrodynamic radius of 36 Å, the same as albumin, are filtered by the glomerular filter (2, 3, 5) . The convergence of the plasma elimination rate constant to values that correspond to the physical size of albumin and IgG, as controlled by renal size selectivity, is substantiated by the fact that the fractional clearances of albumin and IgG in PAN of 0.02 and 0.014, respectively, also correspond to size selectivity (15) . Direct measurement of the GSC of albumin gives a value of 0.03 (9, (31) (32) (33) , which is in agreement with size selectivity estimates and also agrees with the GSC in PAN, where tubular uptake has been inhibited (15, 27) . This demonstrates that the renal retrieval pathways (7-9, 31) for filtered albumin and IgG are high capacity (Table 3 ) and will clearly lead to hypoalbuminemia and hypoimmunoglobulinemia when inhibited in PAN. 
